​

Med Life S.A.

BVB:M Stock Report

Market Cap: RON 3.6b

Med Life (M) Stock Overview

A private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. More details

M fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance4/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 56.8% below our estimate of its fair value

Earnings are forecast to grow 79.57% per year

Earnings grew by 120.7% over the past year

Risk Analysis

Interest payments are not well covered by earnings


M Community Fair Values

Create Narrative

See what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
43.0% undervalued intrinsic discount
59.20%
Revenue growth p.a.
10users have liked this narrative
0users have commented on this narrative
56users have followed this narrative
about 1 month ago author updated this narrative

Med Life S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Med Life
Historical stock prices
Current Share PriceRON 6.65
52 Week HighRON 6.95
52 Week LowRON 5.11
Beta0.62
1 Month Change-3.48%
3 Month Change8.48%
1 Year Change12.90%
3 Year Change40.00%
5 Year Change358.62%
Change since IPO513.85%

Recent News & Updates

Med Life S.A.'s (BVB:M) Price In Tune With Revenues

Apr 10
Med Life S.A.'s (BVB:M) Price In Tune With Revenues

Recent updates

Med Life S.A.'s (BVB:M) Price In Tune With Revenues

Apr 10
Med Life S.A.'s (BVB:M) Price In Tune With Revenues

Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

Aug 06
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Jun 08
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Is Med Life (BVB:M) A Risky Investment?

Apr 05
Is Med Life (BVB:M) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Jul 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Is Med Life (BVB:M) A Risky Investment?

Jan 06
Is Med Life (BVB:M) A Risky Investment?

Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

Dec 06
Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Sep 27
We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Returns Are Gaining Momentum At Med Life (BVB:M)

May 05
Returns Are Gaining Momentum At Med Life (BVB:M)

Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Mar 01
Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Jan 22
Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Aug 31
Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Med Life's (BVB:M) Returns On Capital Are Heading Higher

Jun 10
Med Life's (BVB:M) Returns On Capital Are Heading Higher

Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

May 26
Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

May 12
Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Apr 12
Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Mar 16
Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Mar 04
Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Feb 20
Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Feb 07
Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Jan 25
Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Jan 08
Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Dec 23
Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

Dec 08
Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

The Trends At Med Life (BVB:M) That You Should Know About

Nov 24
The Trends At Med Life (BVB:M) That You Should Know About

Shareholder Returns

MRO HealthcareRO Market
7D-0.7%0.7%0.06%
1Y12.9%20.4%-1.9%

Return vs Industry: M underperformed the RO Healthcare industry which returned 20.4% over the past year.

Return vs Market: M exceeded the RO Market which returned -1.9% over the past year.

Price Volatility

Is M's price volatile compared to industry and market?
M volatility
M Average Weekly Movement4.0%
Healthcare Industry Average Movement4.7%
Market Average Movement5.2%
10% most volatile stocks in RO Market11.4%
10% least volatile stocks in RO Market3.1%

Stable Share Price: M has not had significant price volatility in the past 3 months compared to the RO market.

Volatility Over Time: M's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19966,413Mihail Marcuwww.medlife.ro

Med Life S.A., a private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging investigations; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; preventive and prophylactic healthcare packages; a range of dental services; and fitness services and wellness facilities through Sweat Concept network and Sanopass platform.

Med Life S.A. Fundamentals Summary

How do Med Life's earnings and revenue compare to its market cap?
M fundamental statistics
Market capRON 3.56b
Earnings (TTM)RON 23.95m
Revenue (TTM)RON 2.86b
147.4x
P/E Ratio
1.2x
P/S Ratio

Is M overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M income statement (TTM)
RevenueRON 2.86b
Cost of RevenueRON 1.46b
Gross ProfitRON 1.39b
Other ExpensesRON 1.37b
EarningsRON 23.95m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 29, 2025

Earnings per share (EPS)0.045
Gross Margin48.78%
Net Profit Margin0.84%
Debt/Equity Ratio262.5%

How did M perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/07 22:19
End of Day Share Price 2025/07/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Med Life S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caius RapanuErste Group Bank AG
Marcin NowakIpopema Securities S.A.
Catalin DiaconuRaiffeisen Bank International AG - Institutional Equity